Moreover, the blockade of β-AR signaling effectively abolished the EE-mediated tumor inhibition in Hepa1-6 (Fig. 4G and Supplementary Fig. 5J) and H22 tumor models (Fig. 4H and Supplementary Fig. 5 J). This evidence concerns the gene ADRB2 and neoplasm.